This page lists ClinicalTrials.gov records that name Triptorelin among their listed interventions. Titles, phases, and status are taken from the official registry. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.
Search
Compound
All compounds
Triptorelin
Phase
All phases
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Observational
Not applicable
Expanded access
Status
All statuses
No registered studies match that search or filter.
Recruiting Phase 4 Triptorelin
NCT ID NCT06763926
Sponsor Fundacion Dexeus
Registry dates 2026-10-14 – 2028-01-15
Enrollment 154 registered participants
Locations Spain
Conditions listed Fertility Preservation Registry record on ClinicalTrials.gov
Recruiting Phase 2 Triptorelin
NCT ID NCT07455903
Sponsor Baptist Health South Florida
Registry dates 2026-07-29 – 2031-02
Enrollment 50 registered participants
Locations United States
Conditions listed Prostate Cancer; Localized Prostate Carcinoma Registry record on ClinicalTrials.gov
Recruiting Phase 2 Triptorelin
NCT ID NCT07254429
Sponsor Martin Blomberg Jensen
Registry dates 2025-10-02 – 2028-05
Enrollment 192 registered participants
Locations Denmark
Conditions listed Menopausal Osteoporosis; Bone Markers Registry record on ClinicalTrials.gov
Recruiting Phase 4 Gonadorelin Triptorelin
NCT ID NCT07696351
Sponsor Li-jun Ding
Registry dates 2025-08-01 – 2027-07-31
Enrollment 120 registered participants
Locations China
Conditions listed Deep Infiltrating Endometriosis (DIE); Infertility Registry record on ClinicalTrials.gov
Withdrawn Phase 3 Triptorelin
NCT ID NCT06795191
Sponsor Foresee Pharmaceuticals Co., Ltd.
Registry dates 2025-06-01 – 2028-01-02
Enrollment 0 registered participants
Conditions listed Prostate Cancer Registry record on ClinicalTrials.gov
Recruiting Phase 3 Triptorelin
NCT ID NCT06513962
Sponsor Children's Oncology Group
Registry dates 2025-02-27 – 2029-10-30
Enrollment 60 registered participants
Locations United States, Canada
Conditions listed Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm Registry record on ClinicalTrials.gov
Recruiting Phase 3 HCG Triptorelin
NCT ID NCT07816562
Sponsor Fundación para la Investigación del Hospital Clínico de Valencia
Registry dates 2024-09-17 – 2028-01-01
Enrollment 126 registered participants
Locations Spain
Conditions listed Low Ovarian Reserve; Poor Ovarian Response Registry record on ClinicalTrials.gov
Recruiting Phase 2 Triptorelin
NCT ID NCT06225284
Sponsor National Taiwan University Hospital
Registry dates 2024-08-22 – 2030-12
Enrollment 124 registered participants
Locations Taiwan
Conditions listed Triple Negative Breast Cancer; Premenopausal Breast Cancer Registry record on ClinicalTrials.gov
Not yet recruiting Phase 4 Triptorelin
NCT ID NCT06487143
Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Registry dates 2024-07-01 – 2026-12-30
Enrollment 134 registered participants
Locations China
Conditions listed Central Precocious Puberty Registry record on ClinicalTrials.gov
Recruiting Phase 3 Triptorelin
NCT ID NCT06150703
Sponsor Assistance Publique - Hôpitaux de Paris
Registry dates 2024-06-27 – 2027-09-27
Enrollment 652 registered participants
Locations France
Conditions listed In Vitro Fertilization; ICSI Intracytoplasmic Spermatozoid Injection Registry record on ClinicalTrials.gov
Recruiting Phase 2 Triptorelin
NCT ID NCT06378866
Sponsor Mayo Clinic
Registry dates 2024-06-03 – 2031-02-28
Enrollment 532 registered participants
Locations United States
Conditions listed Recurrent Castration-Sensitive Prostate Carcinoma; Recurrent Prostate Cancer; Castration-resistant Prostate Cancer; Biochemically Recurrent Prostate Carcinoma Registry record on ClinicalTrials.gov
Unknown status Not applicable HCG Triptorelin
NCT ID NCT06481696
Sponsor Andros Day Surgery Clinic
Registry dates 2024-06-01 – 2025-12-31
Enrollment 90 registered participants
Locations Italy
Conditions listed Unexplained Infertility Registry record on ClinicalTrials.gov
Completed Phase 2 Triptorelin
NCT ID NCT05896566
Sponsor ETOP IBCSG Partners Foundation
Registry dates 2024-01-23 – 2025-09-18
Enrollment 231 registered participants
Locations France, Germany, Ireland +3 more
Conditions listed Breast Cancer Registry record on ClinicalTrials.gov
Recruiting Phase 3 Triptorelin
NCT ID NCT06525155
Sponsor Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Registry dates 2024-01-02 – 2025-02
Enrollment 32 registered participants
Locations Indonesia
Conditions listed Endometriosis Registry record on ClinicalTrials.gov
Completed Not applicable Triptorelin
NCT ID NCT06581679
Sponsor Zagazig University
Registry dates 2023-12-15 – 2024-07-01
Enrollment 184 registered participants
Locations Egypt
Conditions listed Adenomyosis Registry record on ClinicalTrials.gov
Recruiting Phase 2, Phase 3 Triptorelin
NCT ID NCT06282588
Sponsor Cancer Research Antwerp
Registry dates 2023-12-13 – 2030-12-31
Enrollment 493 registered participants
Locations Belgium
Conditions listed Prostate Cancer Registry record on ClinicalTrials.gov
Recruiting Phase 2 Triptorelin
NCT ID NCT05851547
Sponsor Ottawa Hospital Research Institute
Registry dates 2023-11-23 – 2028-06
Enrollment 54 registered participants
Locations Canada
Conditions listed Prostatic Neoplasms Registry record on ClinicalTrials.gov
Unknown status Phase 3 Triptorelin
NCT ID NCT05972902
Sponsor Beni-Suef University
Registry dates 2023-07-15 – 2023-12-31
Enrollment 387 registered participants
Locations Egypt
Conditions listed IVF Registry record on ClinicalTrials.gov
Recruiting Phase 3 Triptorelin
NCT ID NCT05328258
Sponsor Kenny Rodriguez-Wallberg
Registry dates 2023-03-31 – 2032-01-31
Enrollment 500 registered participants
Locations Sweden
Conditions listed Breast Cancer Female; Acute Leukemia; Lymphoma; Osteosarcoma +2 more Registry record on ClinicalTrials.gov
Recruiting Phase 3 Triptorelin
NCT ID NCT05781217
Sponsor Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Registry dates 2023-03-14 – 2032-12
Enrollment 534 registered participants
Locations Spain
Conditions listed Prostate Cancer; Salvage Radiotherapy; Biochemical Recurrence; Androgen Deprivation Therapy +1 more Registry record on ClinicalTrials.gov
Completed Observational Triptorelin Results posted
NCT ID NCT05701007
Sponsor Pfizer
Registry dates 2023-02-13 – 2024-04-10
Enrollment 1,083 registered participants
Locations Finland
Conditions listed Metastatic Castration Sensitive Prostate Cancer (mCSPC); Metastatic Castration Resistant Prostate Cancer (mCRPC) Registry record on ClinicalTrials.gov
Recruiting Phase 2 Triptorelin
NCT ID NCT05982093
Sponsor SOLTI Breast Cancer Research Group
Registry dates 2023-02-03 – 2026-12
Enrollment 96 registered participants
Locations Spain
Conditions listed Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Premenopausal Breast Cancer Registry record on ClinicalTrials.gov
Completed Phase 3 Triptorelin Results posted
NCT ID NCT05590793
Sponsor Ipsen
Registry dates 2022-11-17 – 2024-08-20
Enrollment 195 registered participants
Locations China
Conditions listed Advanced Prostate Cancer; Metastatic Prostate Cancer; Locally Advanced Prostate Cancer Registry record on ClinicalTrials.gov
Unknown status Phase 1, Phase 2 Triptorelin
NCT ID NCT04616729
Sponsor Universitair Ziekenhuis Brussel
Registry dates 2022-11-01 – 2025-12-31
Enrollment 30 registered participants
Locations Belgium
Conditions listed Breast Cancer Female Registry record on ClinicalTrials.gov
Completed Phase 3 Triptorelin Results posted
NCT ID NCT05458856
Sponsor Ipsen
Registry dates 2022-08-30 – 2024-07-08
Enrollment 147 registered participants
Locations Belgium, Czechia, France +4 more
Conditions listed Prostate Cancer Registry record on ClinicalTrials.gov